<DOC>
	<DOC>NCT00404742</DOC>
	<brief_summary>The objective of this study is to evaluate the safety and efficacy of LX211 as therapy in subjects with clinically quiescent non-infectious uveitis</brief_summary>
	<brief_title>A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis</brief_title>
	<detailed_description />
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Panuveitis</mesh_term>
	<mesh_term>Uveitis, Posterior</mesh_term>
	<mesh_term>Uveitis, Intermediate</mesh_term>
	<mesh_term>Pars Planitis</mesh_term>
	<criteria>A documented history of noninfectious intermediate, anterior and intermediate, posterior or panuveitis. Minimum prescribed therapy upon enrollment is one or more of the following: systemic prednisone or equivalent averaging ≥ 10 mg/day at least 2 periocular/intravitreal corticosteroid administrations for control of inflammatory disease within the previous 8 months (but not within 6 weeks of randomization). at least one, but not more than 2 immunosuppressive drugs from among the following compounds: cyclosporine, tacrolimus, azathioprine, mycophenolate mofetil, methotrexate Subjects with clinically quiescent uveitis in both eyes at enrollment and who have been on a stable treatment regimen for a minimum of 6 weeks Bestcorrected distance visual acuity in the worst involved eye of 20/400 or better (ETDRS logMAR &lt;1.34) Subjects not planning to undergo elective ocular surgery during the study Evidence of active, uncontrolled noninfectious uveitis Periocular administration of corticosteroids within the previous 6 weeks. Uveitis of infectious etiology Uncontrolled glaucoma Clinically suspected or confirmed central nervous system or ocular lymphoma History or diagnosis of Behçet's disease Primary diagnosis of anterior uveitis</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>uveitis</keyword>
	<keyword>calcineurin</keyword>
</DOC>